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Mini Abstract 
We compared the effect of anthropometric factors on osteoporosis diagnosis by QCT and 
DXA and found QCT spine vBMD was not associated with body weight, BMI or DXA 
anteroposterior spine thickness. In contrast, DXA spine and hip aBMD were strongly 
associated with all three factors. Adjustment of DXA aBMD measurements improved 





































































Purpose Although the diagnosis of osteoporosis using DXA T-scores preferentially targets 
patients with lower body mass index (BMI), there is evidence that obesity is not protective 
against fractures. The aim of this study was to compare the effect of anthropometric factors on 
osteoporosis diagnosis by QCT and DXA and investigate whether adjustment of DXA aBMD 
can achieve a more even distribution of diagnoses between slimmer and heavier individuals 
consistent with QCT.  
Methods The participants were 964 men and 682 women referred for low dose chest CT and 
DXA examinations as part of their employers’ health check-up programs. QCT vBMD was 
measured in the L1-L2 vertebrae and DXA aBMD in the spine and hip. The prevalence of 
osteoporosis in each tertile of BMI in participants aged >50 years was evaluated based on 
their QCT and DXA findings, and then re-evaluated after adjustment to the mean BMI in each 
sex. Similar investigations were performed for body weight and DXA anteroposterior (AP) 
spine thickness. The effect of the adjustment of DXA aBMD for anthropometric factors on 
the correlation with QCT vBMD was also examined.  
Results For spine QCT correlations of age adjusted vBMD residuals against BMI were not 
statistically significant in men (P=0.44) or women (P=0.32). In contrast, slopes for aBMD 
residuals were all highly statistically significant (P<0.001). There were similar findings for 
weight and AP spine thickness. Adjustment of DXA aBMD for anthropometric factors 
resulted in a more equal spread of diagnoses of osteoporosis and greater consistency with 
QCT. 
Conclusion Our study highlights differences between DXA and QCT in their correlation 
with anthropometric factors and its effect on the diagnosis of osteoporosis. Adjustment of 



































































studies are required into whether adjusting DXA aBMD for anthropometric factors has a 
beneficial impact on the discriminative or predictive power for vertebral fracture. 
Key Words: DXA; QCT; Body weight; BMI; Spine thickness; Diagnosis; Osteoporosis 
Introduction 
With the ageing of society, osteoporosis has become a significant health problem around the 
world [1-3]. Bone mineral density (BMD) plays a central role in the diagnosis of osteoporosis, 
the estimation of fracture risk and the monitoring of treatment [1,2,4,5]. BMD is the mass of 
bone mineral per unit volume [the volumetric density (vBMD) in units of mg cm-3] measured 
by quantitative computed tomography (QCT), or per unit area [the areal density (aBMD) in 
units of g cm-2] measured by dual energy X-ray absorptiometry (DXA). Although both can be 
measured in vivo by densitometric techniques, DXA is the most widely used method around 
the world and is recommended by all osteoporosis guidelines [1,2,6]. Although QCT has the 
advantage of measuring the true volumetric BMD and separating trabecular bone from 
cortical bone [7], it features less prominently in guidelines [2,5,8,9]. However, in daily 
clinical practice CT examinations of the abdomen and thoracic region are more frequently 
performed than DXA and present a valuable and underutilised opportunity to acquire 
measurements of hip and spine vBMD [10,11]. 
Although DXA scans predict fracture risk [12], due to their two-dimensional 
projection nature, DXA derived aBMD measurements are subject to a number of limitations 
[4]. Areal aBMD measures the superposition of cortical and trabecular bone and results are 
dependent on bone size. Carter et al. proposed the use of bone mineral apparent density 
(BMAD, g cm-3) to compensate for differences in bone size by correcting aBMD for the 
anteroposterior (AP) spine thickness [13]. Absorptiometric measurements at the spine and hip 



































































manufacturers’ algorithms make assumptions about the homogenous disposition of fat in the 
body that in reality are not true [4]. Studies of the accuracy errors in DXA aBMD 
measurements at the spine and hip caused by soft tissue inhomogeneity suggest that these can 
be substantial [14-16]. Recent studies suggest that obesity may be a risk factor for vertebral 
fracture [17-19]. Liu et al. proposed the use of weight corrected bone mineral content (wBMC) 
to reduce the over-diagnosis of osteoporosis in lighter weight patients and its under-diagnosis 
in heavier patients [20].  Even with the known dependence of aBMD data on bone size and 
body weight, all the national and international osteoporosis guidelines continue to recommend 
the use of DXA aBMD measurements without any adjustment for BMI, weight or bone size 
[1,2,6].  
The adjustment of vBMD and aBMD measurements for anthropometric factors such 
as BMI, weight and AP spine thickness and their impact on the diagnosis of osteoporosis has 
not been investigated before using QCT and DXA scans in the same population. Therefore, in 
the present study we sought to determine the effect of BMI, weight and bone size on vBMD 
by QCT and aBMD by DXA using data from a healthy Chinese population referred for their 
annual health check-up. After finding that all three factors were significant predictors of DXA 
aBMD, but not for QCT vBMD, we explored the impact of the adjustment of DXA aBMD for 
anthropometric factors on the diagnosis of osteoporosis and the correlation between aBMD 
and QCT vBMD.  
Material and Methods 
Participants 
The study was approved by the ethics committee of Beijing Jishuitan Hospital and 
each participant gave written informed consent for their data to be used. Participants were a 



































































registered with the US clinical trials database (clinicaltrials.gov; trial identifier: 
NCT03699228) [21]. The subjects were >30 years old and were originally referred to the 
health management centres of the affiliated hospital of Guiyang Medical University, and the 
affiliated Yijishan Hospital of Wannan Medical University, as part of their employers’ health 
check-up programs, and received a low dose chest CT (LDCT) scan for lung cancer screening 
and a DXA examination for the measurement of aBMD with both scans performed on the 
same day. Subjects with metal implants within the CT or DXA scan fields were excluded. A 
total of 964 men and 682 women were included in the study, which involved the post-scan 
processing of CT and DXA scans. No additional radiation was involved. 
Anthropometry measurements 
 Weight (kg) and height (m) were measured using calibrated digital scales and 
stadiometers and body mass index was calculated [BMI = weight (kg)/height (m)2]. Following 
the definition of BMAD by Carter et al., DXA AP spine thickness was defined as the square 
root of the average projected area of the L2-4 vertebra [√(L2-4 area/3)] [13].  
QCT and DXA scans 
 The details of the China Biobank study protocol have been published elsewhere [21]. 
All participants in this study received an annual health check-up as part of their employer’s 
workplace welfare scheme. LDCT scans were conducted on a Supria CT scanner (Hitachi, 
Tokyo, Japan) at the Guiyang centre and an Optima CT540 CT scanner (GE Healthcare, WI, 
USA) at the Wannan centre. LDCT is now the standard for lung cancer screening [22] and the 
subsequent analysis of these CT scans enabled evaluation of vBMD at L1 and L2 using the 
Mindways QCT Pro software calibrated with a QCT phantom (Mindways, Austin, TX, USA) 



































































of trabecular bone in the mid-plane of each vertebral body, not including cortical bone or the 
basivertebral plexus. 
 DXA measurements of aBMD and lumbar spine projected area were conducted using 
GE Lunar DXA (GE Lunar Prodigy and DPX Bravo DXA scanners, GE Healthcare, WI, 
USA) systems, GE Lunar Encore software and GE Lunar positioning devices to enable 
consistency and accuracy of patient positioning. The lumbar spine (L2-4) scan was performed 
at the Wannan Centre, and scans of the lumbar spine (also L2-4) and hip were performed at 
the Guiyang Centre. DXA and LDCT were performed on the same day. All data were 
transferred to the Data Management Centre (Beijing Jishuitan Hospital) for data cleaning and 
analysis. 
Statistical Analysis 
All statistical analyses were performed using Microsoft Excel and the Vassarstats 
statistical computation web browser [23]. Where descriptive data were normally distributed 
results were described as the mean and standard deviation (SD) and analysed using parametric 
statistical tests. Otherwise, data were described by the median and analysed using non-
parametric tests.  
BMD measurements at each site were plotted against age and fitted by linear regression. 
In men, QCT spine vBMD values declined linearly with age between 30 and 60 years, with a 
slower rate of loss in those aged >60 years, and the data were fitted in two segments. For 
DXA spine aBMD, a number of the men age >70 years had elevated BMD results attributed 
to degenerative disease. Therefore men in this age group were excluded from further analysis 
and the data for men <70 years fitted by a single regression line. DXA femoral neck and total 
hip BMD were both fitted by a single regression line over all ages. For women the plots of 



































































women aged <45 years, a linear decrease from age 45 to 60, and a shallower linear decrease 
in those aged >60. Since QCT and DXA measurements have different units (mg cm-3 and g 
cm-2 respectively) the residuals from the linear regression lines were converted into Z-scores 
by dividing by the young adult population SD (QCT: 25 mg cm-3, spine DXA and femoral 
neck DXA in women: 0.12 g cm-2, other DXA sites: 0.13 g cm-2). Z-scores for each sex and 
skeletal site were plotted against age to confirm that the mean Z-score and slope of the 
regression line were both zero.  
Z-scores were also plotted against weight, height, BMI and AP spine thickness. At each 
DXA site the correlation coefficient was largest for the scatter plot against weight, least for 
the plot against height and intermediate for BMI and spine thickness (Table 1). Weight, BMI 
and spine thickness were therefore selected as anthropometric factors for further analysis and 
the slopes of their regression lines with Z-score and their standard errors (SE) evaluated for 
men and women for QCT and each DXA site. From this analysis it was unclear whether a 
linear relationship between Z-score and the anthropometric measurement applied over the 
entire range. For weight this relationship was examined by dividing subjects into 10 kg 
intervals (men: 40-49, 50-59, 60-69, 70-79, 80-89 and 90+ kg; women 40-49, 50-59, 60-69, 
70-79 and 80+ kg) and the mean Z-score and SE for each bin plotted against weight. Chi-
squared tests were performed to evaluate the goodness of fit of the points to a straight line.  
The prevalence of osteoporosis in men and women aged 50 years and over was 
evaluated based on their QCT and DXA findings. For QCT, osteoporosis was defined as 
vBMD <80 mg cm-3. For DXA, T-scores were calculated using the GE-Lunar China reference 
ranges and osteoporosis defined according to the WHO Task Group criterion of a spine or 
femoral neck T-score  < -2.5 [4]. For each anthropometric factor (weight, BMI or spine 
thickness) participants were divided into three equal tertiles and the prevalence of 



































































the prevalence of osteoporosis was re-evaluated after spine and femoral neck BMD values 
were adjusted for weight, BMI or spine thickness to their average value in men and women 
respectively. Results for the different tertiles were compared in a 3 x 2 contingency table 
using Fisher’s exact test. To further evaluate the effects of adjusting DXA aBMD values, 
QCT vBMD measurements of participants were plotted against DXA spine T-scores, femoral 
neck T-scores and the lower of the two T-scores. The correlation coefficients for each sex 
were evaluated before and after adjustment for weight, BMI and spine thickness and the 
statistical significance of the difference between the two correlation coefficients determined 
[24]. A P-value < 0.05 was taken to be statistically significant.  
Results 
A total of 964 men and 682 women received QCT and DXA lumbar spine bone density 
measurements. Of these, 635 men and 402 women also received DXA hip measurements. 
Table 2 gives the participants’ descriptive statistics.  
Figure 1A shows the scatter plot of DXA spine Z-score against age for men. Points 
plotted in red for the men >70 years old included a number of individuals with high Z-scores 
suggestive of spinal degenerative disease, and these individuals were removed from further 
analysis. For the men <70 years the mean Z-score and the slope of the regression line of Z-
score against age were both zero. Plots of Z-score against age for women and for QCT and 
hip DXA in men did not show any similar anomaly.  
Figure 1B shows the scatter plot for DXA spine Z-score against body weight for the 
men <70 years old in Figure 1A together with the linear regression line (solid red line) and 
95% confidence interval (dashed red lines). The slope and standard error were 0.0393  
0.0038 Z-score units per kg. Similar results with slopes 8 to 10 times greater than the standard 



































































weight for spine QCT in men (P = 0.82) and women (P = 0.30) were not significantly 
different from zero. Findings for plots of QCT and DXA Z-scores against BMI and spine 
thickness were similar to those for weight (Figures 1C,D).  
Figures 2A-C compare the slopes of the QCT and DXA Z-score regression lines in men 
and women at the different measurement sites for the three anthropometric factors together 
with their 95% confidence intervals (CI). In Table 3 the same slopes are listed in BMD units 
(for example g/cm2 per kg instead of Z-score units per kg) together with the values of the 
population SD used to convert Z-scores into BMD units.  
Figure 3 shows the mean Z-score in each 10 kg interval of body weight plotted against 
mean weight for the QCT spine and DXA spine and femoral neck sites in men and women 
respectively. The error bars show the 95% CI. In each plot the red line is the linear regression 
line evaluated as shown in Figure 1B. For each BMD site the results of the chi-squared test 
show that the regression line is a good fit to the data points. Results for the total hip site (not 
shown) were similar to the femoral neck.   
The percentages of men and women aged 50 years and over with osteoporosis in each 
tertile of body weight, BMI and AP spine thickness are plotted in Figures 4A-C respectively. 
Each panel of Figure 4 compares the prevalence of osteoporosis in each tertile for QCT 
vBMD (left-hand set of three points), conventional DXA aBMD (middle set of three points), 
and DXA aBMD adjusted for the respective anthropometric factor (right-hand set of three 
points). Error bars show the 95% CI. DXA aBMD measurements were adjusted to the mean 
value of the anthropometric factor in each sex. Further details including the adjustment factors 
are given in the caption to Figure 4. The overall prevalence of osteoporosis diagnosed by 
QCT was 16.3% in women and 5.4% in men, and for DXA was 15.6% in women and 3.0% in 



































































osteoporosis as diagnosed by QCT was independent of weight (P = 0.89), while for 
conventional DXA there was a statistically significant trend for the prevalence of osteoporosis 
to decrease at higher weights (P = 0.026) that was no longer significant after adjusting aBMD 
values for weight (P = 0.31). The number of men with osteoporosis was too low for any of the 
differences to be statistically significant. The findings for tertiles of BMI and spine thickness 
were similar (Figure 4B,C). When the highest and lowest tertiles were compared using 2 x 2 
contingency tables the P-values of the unadjusted vs. adjusted DXA results were 0.013 vs. 
0.29, 0.0019 vs. 0.29 and 0.019 vs. 1.0 for weight, BMI and spine thickness respectively. 
When the correlation coefficients of DXA spine T-score, femoral neck T-score and the 
lower of the two T-scores against QCT spine vBMD were plotted for men and women before 
and after adjustment for anthropometric factors there was a trend for the correlation 
coefficients to increase after adjustment and half the increases were statistically significant (P 
< 0.001) (Figure 5).  
Discussion 
This study aimed to investigate the influence of anthropometric factors such as body 
weight, BMI and AP spine thickness on the diagnosis of osteoporosis by QCT and DXA in a 
large cohort of healthy Chinese subjects. The overall prevalence of osteoporosis was similar 
in both sexes whether it was diagnosed by QCT or DXA. However, when participants were 
divided into tertiles of weight, BMI or spine thickness the prevalence of osteoporosis 
diagnosed by QCT was consistent across all three tertiles, while for DXA there were 
pronounced gradients with subjects with lower weight, BMI or spine thickness having a 
higher prevalence of osteoporosis compared with those with larger values. When DXA 
measurements were adjusted for weight, BMI or spine thickness using slopes of regression 



































































tertile and increased in the higher tertile and findings were more consistent with those for 
QCT. There was also a trend for adjusted DXA T-scores to correlate more strongly with QCT 
vBMD, and in half the correlations the increases were statistically significant.  
DXA uses attenuation measurements at two X-ray photon energies to minimise the 
influence of different soft tissue thickness and body composition over the scan area on the 
accuracy of aBMD measurements [25]. DXA aBMD measurements are the product of the 
average volumetric BMD and AP bone thickness in each pixel averaged over the bone region 
of interest (ROI). As such, measurements are sensitive to bone size as well as the true 
volumetric BMD making it more complicated to interpret results in children compared with 
adults and explaining some of the differences in reference ranges between men and women 
and between different ethnic groups. In contrast, QCT measures the true volumetric BMD 
independently of bone size or the thickness and composition of extraosseous soft tissue. The 
dependence of DXA aBMD on AP bone thickness and inhomogeneity in body composition 
may explain the striking differences compared with QCT in the correlation coefficients in 
Table 1 and slopes in Figure 2. The slopes of the regression lines with body weight in Figure 
2A are similar for the spine and hip sites and between men and women. This suggests that a 
variation of bone size with body weight may be a factor in explaining the weight correlations 
found for DXA. Another explanation might be the increased stresses put on bone in heavier 
individuals, although it is notable that the absence of any effect on QCT measurements 
excludes an effect of body weight on spinal trabecular vBMD. A third explanation might be 
that in heavier individuals there is a systematic difference in the thickness of adipose tissue 
(AT) between the bone and soft tissue reference ROIs [14-16] and the effect of increasing 
BMI on aBMD is a soft tissue measurement error rather than a real difference. Tothill et al. 
estimated that 10 mm of AT thickness was equivalent to -0.043 g/cm2 of hydroxyapatite[14], 



































































explained by AT thickness differences of 11 to 15 mm per 10 kg increase in body weight. 
Further investigations of this issue could include direct measurements of bone sizes using CT 
images, a comparison of integral aBMD in the hip measured with QCT compared with DXA, 
or measurements of adipose tissue thickness and its variation with BMI using CT or MRI 
imaging.  
Carter et al. were the first to compensate for differences in bone size by dividing aBMD 
by the square root of the projected area to give an estimate of volumetric BMD referred to as 
bone mineral apparent density (BMAD) [13]. Unlike QCT and DXA BMD measurements, 
there is no accepted threshold for the diagnosis of osteoporosis using BMAD. For this reason 
we used the DXA AP spine thickness defined as the square root of the average projected area 
of the L2-4 vertebrae as an anthropometric factor predicted to correlate with DXA spine 
aBMD. Mean value of L2-4 BMAD for the study participants was 0.28 g cm-3 in men and 
0.29 g cm-3 in women, comparable to the spine aBMD adjustment factor of 0.23 g cm-3 
inferred from the scatter plots (Table 3). Unsurprisingly, the bone thickness inferred from 
spine DXA measurements did not correlate as well with aBMD measurements made in the 
hip (Table 1 and Table 3).  
Recently, Liu et al. proposed the use of weight corrected bone mineral content (wBMC) in the 
spine and hip obtained by dividing the BMC in each ROI by body weight [wBMC = 
BMC/weight (g/kg)] so that body weight rather than projected area is used for BMC 
standardisation [20]. They showed that defining osteoporosis in terms of wBMC T-scores 
removed the trend with conventional DXA aBMD for a greater proportion of patients in the 
lower tertile of body weight to be diagnosed with osteoporosis than those in the upper tertile, 
resulting in a more even distribution of diagnoses across the full range of body weights 
similar to that for QCT in Figure 4 of the present paper. Our use of the slopes of the 



































































effect in re-balancing the prevalence of osteoporosis, ensuring a more equal spread of 
diagnoses and greater consistency with QCT.  
The findings of Liu et al. [20] and the difference between QCT and DXA in the 
distribution of cases of osteoporosis across the range of body weights raises the question of 
whether there is any justification for the goal of levelling out diagnoses of osteoporosis across 
different body weights, or whether the present bias with DXA that directs anti-fracture 
therapies preferentially towards lower weight patients achieves the best overall clinical 
outcome. Since the aim of fracture prevention is paramount, this is an issue that can only be 
decided using fracture data. There is evidence that, despite greater soft tissue mass and 
thickness, obesity is not protective against fracture, particularly at the spine and appendicular 
skeletal sites [17-19]. A recent study in Shanghai, China, reported that the prevalence of 
vertebral deformity in men was similar to that in women (17% vs. 17.3%) over 60 years [26] 
and a three-fold higher vertebral fracture prevalence in men has been reported elsewhere [17]. 
The application of a body weight or BMI correction for DXA BMD measurements may 
improve the identification of people at risk of fracture, especially in obesity, which has been 
identified as a risk factor for falls in men [27]. The fact that QCT vBMD is not associated 
with body weight indicates that heavier weight does not have a beneficial effect on spine 
trabecular vBMD, suggesting it may not be protective against fracture. Our findings suggest 
that the ability of weight, BMI or spine thickness corrected aBMD to predict fracture risk 
warrants further investigation.  
Our findings may have further relevance. The WHO diagnostic criteria for osteoporosis 
and osteopenia were developed and validated on data for postmenopausal women and then 
extended to men without the same rigorous validation seen in women. One consequence is 
that the prevalence of osteoporosis in men may be higher than that currently projected by 



































































study was 13 kg heavier than women, and adjustment of men’s results to the mean body 
weight in women may re-dress this imbalance. Our findings may have relevance for the 
longitudinal monitoring of aBMD, particularly in populations where large changes in body 
weight are expected, such as in patients undergoing bariatric surgery, in cancer patients after 
chemotherapy and in children [28-32]. The rapid decline in the BMD of these patients may 
reflect more the influence of weight loss on the aBMD measurement than their true bone loss, 
especially given that QCT assessment of vBMD has demonstrated a negligible decline 
compared with aBMD [29-32]. 
Our study has several limitations. Firstly, this is a cross sectional study and no fracture 
information was available. Therefore, it was not possible to compare the performances of raw 
DXA aBMD, adjusted aBMD and QCT vBMD for predicting fracture risk. Further studies are 
required into whether obesity is a protective factor against fractures and whether adjusting 
DXA aBMD for anthropometric factors has a beneficial impact on the discriminative or 
predictive power for vertebral fracture. Secondly, there were few men with osteoporosis. It 
was necessary to exclude men over 70 years old from the DXA spine analysis because of the 
high incidence of spinal osteoarthritis in these participants and their consequent elevated 
BMD findings. Failure to exclude these men would have prejudiced the power of the study to 
explore the relationship between body weight and spine aBMD.   
In conclusion, in this study we report that, after adjustment for gender and age, QCT 
spine vBMD was not associated with body weight, BMI or spine bone thickness. In contrast, 
after adjustment for gender and age, DXA spine and hip aBMD were strongly associated with 
all three anthropometric factors. We determined adjustment factors for body weight of 0.005 
g cm-2 kg-1 and 0.006 g cm-2 kg-1 for men and women respectively, for BMI of 0.013 g cm-2 
kg-1 m2 in both sexes, and for spine thickness of 0.23 cm-1 for spine aBMD and 0.15 cm-1 for 



































































rebalance the diagnosis and management of osteoporosis between patients with higher and 
lower than average body size making DXA outcomes more consistent with QCT vBMD. 
Further studies are required into whether adjusting DXA aBMD for anthropometric factors 
has a beneficial impact on the discriminative or predictive power for vertebral fracture. 
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Table 1: Pearson correlation coefficients of body weight, body mass index (BMI),  
DXA spine (L2-4) thickness and height with QCT and DXA BMD Z-score 
 
 
 Pearson Correlation Coefficient with Z-score† 
Gender BMD site Weight BMI 




DXA Spine 0.322 (P<0.001) 0.259 (P<0.001) 0.261 (P<0.001) 0.168 (P<0.001) 
DXA Fem 
Neck 
0.362 (P<0.001) 0.275 (P<0.001) 0.191 (P<0.001) 0.220 (P<0.001) 
DXA Total 
Hip 
0.388 (P<0.001) 0.347 (P<0.001) 0.147 (P<0.001) 0.151 (P<0.001) 
QCT Spine 0.007 (P=0.82) 0.025 (P=0.44) -0.068 (P=0.035) -0.023 (P=0.47) 
Women 
DXA Spine 0.305 (P<0.001) 0.217 (P<0.001) 0.266 (P<0.001) 0.171 (P<0.001) 
DXA Fem 
Neck 
0.399 (P<0.001) 0.347 (P<0.001) 0.213 (P<0.001) 0.119 (P=0.017) 
DXA Total 
Hip 
0.406 (P<0.001) 0.398 (P<0.001) 0.241 (P<0.001) 0.037 (P =0.50) 
QCT Spine 0.040 (P=0.30) 0.038 (P=0.32) 0.068 (P=0.078) 0.009 (P=0.82) 
 
 
†: Z-scores calculated after adjusting BMD for age and normalizing to the population 
standard deviation values listed in Table 3 
 





































































Table 2: Descriptive statistics of subjects (mean and SD) 
 
 
 Men Women P-value 
N 964 682  
Age (y) 50.8 (10.2) 52.6 (10.5) P < 0.001 
Weight (kg) 70.3 (9.6) 57.3 (8.1) P < 0.001 
Height (m) 1.68 (0.06) 1.56 (0.06) P < 0.001 
BMI (kg m-2) 24.8 (3.0) 23.6 (3.2) P < 0.001 
DXA Spine Area (L2-4) (cm2) 46.3 (3.9) 39.4 (3.6) P < 0.001 
DXA Spine Thickness (cm) 3.93 (0.16) 3.56 (0.16) P < 0.001 
QCT vBMD L1-2 mg cm-3 130.4 (31.4) 126.2 (43.6) P = 0.022 
DXA aBMD L2-4 g cm-2 1.124 (0.152) 1.070 (0.180) P < 0.001 
DXA aBMD femoral neck g cm-2 0.920 (0.134) 0.858 (0.136) P < 0.001 
DXA aBMD total hip g cm-2 0.984 (0.130) 0.912 (0.140) P < 0.001 
 
BMI: Body mass Index. Among the men 1.5% were underweight (BMI < 18.5), 52.6% were 
normal (BMI 18.5-24.9), 40.5% were overweight (BMI 25-29.9) and 5.5% were obese (BMI 




































































Table 3:  Anthropometric BMD corrections by gender and QCT or DXA BMD measurement 
site. Slopes for body weight, BMI and spine thickness are expressed in BMD units per kg, per 
kg m-2 and per cm respectively 
 
 






(g cm-2 kg-1) 
BMI 
Slope (SE)* 
















































































* Slopes in BMD units obtained by multiplying the slopes in Z-score units plotted in Figures 
1, 2 and 3 by the population SD in column 3.   











































































Scatter plots for men of DXA spine aBMD (L2-4) Z-score against: (A) age; (B) body weight; 
(C) body mass index (BMI); (D) anteroposterior spine thickness expressed as √(L2-4 Area/3). 
Men over 70 years old plotted as red dots in (A) were excluded from the scatter plots in (B), 
(C) and (D) because of individuals with high Z-scores likely to be due to degenerative disease. 
The red continuous lines are the linear regression lines. Red dashed lines show the 95% 
confidence intervals. The slopes are expressed in Z-score units and the statistical error is ± 1 









































































Slopes of Z-score against: (A) body weight; (B) BMI; (C) DXA AP spine thickness for QCT 
and DXA BMD measurements by gender and measurement site. Values plotted are the results 
of linear regression analysis similar to that shown for male spine DXA in Figures 1B-D. Error 









































































Plots for men and women of mean Z-score in 10 kg intervals of body weight against mean 
body weight for that interval. Plots are for: (A) QCT spine (L1-2); (B): DXA spine (L2-4); 
(C) DXA femoral neck in men; (D) QCT spine (L1-2); (E): DXA spine (L2-4); (F) DXA 
femoral neck in women. Error bars show the 95% confidence intervals. The red lines are the 
linear regression lines obtained from scatter plots similar to Figure 1B. For each BMD site the 







































































Percentage of women and men aged 50 years and over with osteoporosis plotted for tertiles of 
(A) body weight; (B) BMI; (C) AP spine thickness [= √(L2-4 Area/3)]. In each panel the left-
hand set of three points refer to QCT spine vBMD, the middle three points to conventionally 
interpreted DXA aBMD, and the right-hand three points to DXA aBMD adjusted for the 
respective anthropometric factor. Error bars show the 95% confidence intervals. For QCT, 
osteoporosis was defined as a mean trabecular vBMD in the L1-2 vertebrae < 80 mg cm-3. For 
DXA, osteoporosis was defined as a T-score at the spine (L2-4) or femoral neck T < -2.5. P-
values are the statistical significance of the difference in each set of three tertiles in women 
evaluated using Fisher’s Exact Test. None of the differences in men were statistically 
significant.  
Body weight adjustment: spine and femoral neck DXA aBMD were adjusted to mean weights 
of 70 kg in men and 58 kg in women using corrections of 0.005 g cm-2 kg-1 and 0.006 g cm-2 
kg-1 in men and women respectively. For men the lowest, middle and highest tertiles were 
41.0-66.0, 66.1-73.9 and 74.0-110.5 kg respectively. In women they were 37.9-53.4, 53.5-
59.6 and 59.7-95.5 kg.  
BMI adjustment: spine and femoral neck DXA aBMD were adjusted to a mean BMI of 25.0 
kg m-2 in men and 24.0 kg m-2 in women using a correction of 0.013 g cm-2 kg-1 m2 in both 
sexes. For men the lowest, middle and highest tertiles were 15.6-23.9, 24.0-25.9 and 26.0-
35.9 kg m-2 respectively. In women they were 14.9-22.8, 23.0-25.9 and 26.0-33.8 kg m-2.  
Spine thickness adjustment: spine and femoral neck DXA aBMD were adjusted to a mean 
thickness of 3.9 cm in men and 3.6 cm in women using corrections of 0.23 g cm-3 for spine 
BMD and 0.15 g cm-3 for femoral neck BMD in both sexes. For men the lowest, middle and 
highest tertiles were 3.36-3.88, 3.88-4.01 and 4.01-4.88 cm respectively. In women they were 






































































Plots of correlation coefficients of DXA spine T-score, femoral neck T-score and the lower of 
the two T-scores against QCT spine vBMD for: (A) men, and (B) women before and after 
adjustment for weight, BMI and spine thickness. Error bars show ± 1SE for each correlation 
coefficient. P-values are the results of comparing adjusted and unadjusted T-scores after 
testing for the difference between two dependent correlations with one variable in common 
[25].  
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
